Table 1 Association between TBC1D5 mRNA expression and clinicopathological parameters of patients with ccRCC
Patient characteristics | ||||
|---|---|---|---|---|
Parameter | TBC1D5 mRNA expression | P-value | ||
No | Low (n = 265) | High (n = 266) | ||
Age | ||||
≤ 60 | 263 | 113 | 150 | |
> 60 | 268 | 152 | 116 | 0.002 |
Tumor stage | ||||
Stage 1 or 2 | 322 | 139 | 183 | |
Stage 3 or 4 | 209 | 128 | 81 | 0.000 |
T stage | ||||
T1 or T2 | 340 | 150 | 190 | |
T3 or T4 | 191 | 115 | 76 | 0.000 |
N stage | ||||
N0 | 239 | 116 | 123 | |
N1 or NX | 292 | 149 | 143 | 0.505 |
M stage | ||||
M0 | 441 | 204 | 237 | |
M1 or MX | 90 | 60 | 30 | 0.000 |
Histologic grade | ||||
< 8 | 241 | 103 | 138 | |
≥ 8 | 290 | 164 | 126 | 0.002 |
Gender | ||||
Acinar type | 187 | 105 | 82 | |
Other subtype | 344 | 160 | 184 | 0.034 |
Primary tumor side | ||||
No | 254 | 136 | 118 | |
Yes | 277 | 129 | 148 | 0.108 |